Democritus University of Thrace (DUTH)
Ανάλυση του προτύπου γονιδιακής έκφρασης κατά την αγγειογένεση σε ανθρώπινους όγκους
Abstract
dc:descriptionThe gene expression profile of tumor vasculature is different from normal vasculature, offering new opportunities for diagnosis and therapy of cancer. We identified 234 genes overexpressed in ovarian tumor vascular cells with the use of Affymetrix microarrays and we evaluated the usefulness of these genes in clinical applications such as diagnosis, prognosis and treatment of Epithelial Ovarian Cancer (EOC). The methodology we used includes the determination of the expression levels of these genes in numerous normal as well as cancer human specimens at the mRNA and protein level. We also examined the correlation between the expression levels of these genes with clinical outcome of patients. Our results demonstrate that several transmembrane proteins, such as ADAM12 and CDCP1, are expressed exclusively by the endothelium of cancer tissues and represent possible targets for vascular imaging or anti-vascular therapy of EOC. Concentrations of the secreted molecules DR6 (TNFRSF21), ESM1 (endocan) and CSPG2 (versican) were measured in sera of patients. Each of these markers can improve the diagnostic performance of CA125. These observations were repeated in different patient cohorts of different origin. Furthermore, the prognostic potential of 5 tumor vascular markers was evaluated at the protein level with dot blots (AML1, MCM4) in a cohort of 70 EOC patient biopsies and with luminex assays (DR6, ESM1, CSPG2) in 81 patient sera. Increased AML1 (p=0.056) and MCM4 (p=0.027) protein levels correlate with positive and negative clinical outcome respectively. DR6 (p=0.004), ESM1 (p=0,016) and CSPG2 (p=0.0002) high serum protein levels correlate with infavorable clinical outcome. The experiment was repeated in a separate cohort of 117 patients with comparable results. In conclusion, we have identified novel tumor-specific vasculature markers which appear promising for cancer serum diagnostics, disease prognosis, molecular imaging and possibly therapeutic targeting applications and warrant further clinical development.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sasaroli, Dimitra
- Σασαρώλη, Δήμητρα
Subjects
dc:subject × 20Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18815